FindTrial
Sign In

GLP1 receptor agonist

DRUG6 trials

Sponsors

University of California, San Francisco, Sanofi, Weill Medical College of Cornell University, Hôpital Fribourgeois, Hartford HealthCare

Conditions

Bariatric SurgeryDiabetes Mellitus, Type 2Fecal IncontinenceGLP-1Glucagon-Like Peptide-1 Receptor AgonistsIPMNIPMN, PancreaticIntraductal Papillary Mucinous Neoplasm of Pancreas

Early Phase 1

Changes in plasma aldosterone and renin level in obesity and type 2 diabetes mellitus patient after GLP1 receptor agonist
RecruitingTCTR20260123002
Faculty of Medicine, Chiang Mai UniversityOver the past decade, the incidence of overweight and obesity has increased dramatically worldwide. According to a WHO survey, in 2022 there were approximately 1 billion people who were obese or overweight, representing a threefold increase compared with 1975 . Obesity is considered a major risk factor for metabolic syndrome (including insulin resistance, dyslipidemia, and hypertension), which subsequently leads to an increased risk of cardiovascular and cerebrovascular events, as well as higher
Start: 2025-09-01Target: 30Updated: 2026-03-30

Phase 4

A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in Turkey
CompletedNCT02954692
SanofiType 2 Diabetes Mellitus
Start: 2016-11-30End: 2017-12-22Updated: 2019-01-14

Unknown Phase

Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
CompletedNCT02846233
University of California, San FranciscoType 2 Diabetes Mellitus
Start: 2016-08-31End: 2018-12-31Updated: 2020-11-10
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney Disease
CompletedNCT03921242
Weill Medical College of Cornell UniversityDiabetes Mellitus, Type 2, Renal Insufficiency, Chronic
Start: 2019-08-01End: 2023-08-01Updated: 2023-11-09
Impact of GLP-1 Receptor Agonists on Patients With IPMN
Not yet recruitingNCT07014709
Hôpital FribourgeoisGLP-1, Glucagon-Like Peptide-1 Receptor Agonists, Intraductal Papillary Mucinous Neoplasm of Pancreas +2
Start: 2025-05-31End: 2026-10-31Target: 30Updated: 2025-06-11
Pelvic Floor Disorder Symptoms in Women Seeking Weight Loss Therapy
Not yet recruitingNCT07175805
Hartford HealthCareBariatric Surgery, Fecal Incontinence, glp1 Agonist +6
Start: 2025-10-31End: 2027-06-30Target: 200Updated: 2025-09-16

Related Papers

SUN-LB115 Is the Stepping-Down Approach a Better Option Than Multiple Daily Injections in Patients With Chronic Poorly-Controlled Diabetes on Advanced Insulin Therapy?
Journal of the Endocrine Society2020-04-011 citations